News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

Discover a new AI-driven tool that uses single-cell RNA data to help predict patient responses to cancer treatments.

NCI-funded researchers used machine learning to characterize a cancer biomarker based on exosomes. Their biomarker worked well using non-invasive sources, such as blood and urine, allowing the researchers to catch cancer early, even in tumors of undetermined origins.

Learn about NCI’s LORIS, a new artificial intelligence-approach to help you predict how a patient will respond to immunotherapy.

Can you develop an algorithm that applies to every patient, in every situation? A recent study shows the importance of adding diversity to your data when developing AI models.

Want to identify existing gene mutations more accurately and discover new signatures more efficiently? There’s a new NCI-funded tool, the Mutational Signature Calculator, that can help improve your standard workflow.

Are you researching immunotherapies and having trouble predicting which epitope will deliver the biggest punch? Try this new model for predicting immunogenicity, which is reportedly outperforming current models.

NIH and the National Science Foundation are participating in an interagency funding opportunity that seeks to address technological and data science challenges, which require fundamental research and development of new tools, workflows, and methods. Proposals are due October 3, at 5:00 p.m. (submitter’s local time).

A new machine learning model blends image data with clinical and pathological information to tailor care for patients with breast cancer.

Are you ready to introduce AI into your practice? NCI-funded researchers recently conducted a survey to help shed light on how oncologists feel about using AI in cancer care.

Do you conduct research on statistical and analytical methods, cancer survivorship, digital health, and/or data science tools and methods? Apply for an R01 grant from NCI’s Division of Cancer Control and Population Sciences by June 5 or October 5, 2024.